Survey on primary tuberculosis in Gironde (France);Enquete sur les cas de primo-infection tuberculeuse dans le departement de la Gironde

Revue des Maladies Respiratoires

Volumn 16, Issue 5, 1999, Pages 823-828

  Portel, L ^a   Salamon, M ^c   Pasquet, S ^b   Tessier, J F ^b   Daucourt, V ^b   Dabis, F ^b   Courty, G ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c Service des Actions de Santé   (France)

Author keywords

BCG; Primary tuberculosis; Vaccination

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; FRANCE; HUMAN; MALE; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS; ADOLESCENT; ADULT; AGE; COMPARATIVE STUDY; INFANT; LUNG TUBERCULOSIS; NEWBORN; PRESCHOOL CHILD; QUESTIONNAIRE; REGISTER; SEX DIFFERENCE; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; QUESTIONNAIRES; REGISTRIES; SEX FACTORS; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 0032793855     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. FLAMENT-SAILLOUR M, PERONNE Ch : Histoire naturelle de l'infection tuberculeuse et réaction cutanée tuberculinique. Rev Mal Respir 1997;14:5S27-5S32.
2. MURRAY JF, BURNS J : Amberson lecture: the white plague: down and out or up and coming ? Am Rev Resp Dis 1989;140:1788-95.
3. ROUILLON A, ENARSON DA, CHRÉTIEN J : Epidémiologie de la tuberculose dans le monde. Encycl Méd Chir (Elsevier, Paris), Pneumologie, 6-019-A-32,1996,15 p.
4. AIT KHALED N, ENARSON D, BILLO N : Epidémiologie de la tuberculose et de la résistance aux anti-tuberculeux. Rev Mal Resp 1997;14:5S8-5S18.
5. PASQUET S, DABIS F, TESSIER J-F et al. : Epidémiologie de la tuberculose en Gironde : Résultats d'une surveillance active en 1995. BEH 1997;27:125-6.
6. UICTMR : Criteria for discontinuation of vaccination in countries with a low tuberculosis: a statement of international union against tuberculosis and lung disease. Tuber Lung Dis 1994;75:179-81.
7. BÉGUÉ P, CARBONNELLE B, CARTIER F et al. : La tuberculose en France : Comment arrêter l'épidémie actuelle ? Conférence de consensus. Rev Mal Resp 1995;12:R132-R157.
8. COLDITZ G, BREWER T, BERKEY T et al. : Efficacy of BCG vaccine in prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702.
9. HUCHON G : Tuberculoses et mycobactérioses non tuberculeuses. Encycl Méd Chir (Elsevier, Paris), Pneumologie, 6-019-A-33,1997,20 p.
10. SALAMON M, METZGER-PORTE MH, LE LOUARN A : Estimation de la couverture vaccinale des enfants nés en 1989 scolarisés dans les écoles publiques et privées de la Gironde. Enquête du service des actions de santé. Direction Solidarité Gironde.
11. KELLY P, MC KEOWN D, CLANCY L : Neonatal vaccination in Ireland: Evidence of its efficacy in the prevention of childhood tuberculosis. Eur Respir J 1997;10:619-23.
12. D'ARCY HART P, SUTHERLAND I : Final report to the medical research council, BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977;2:293-5.
13. AMERICAN THORACIC SOCIETY 1993 : Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74.
14. HONG KONG CHEST SERVICE, TUBERCULOSIS RESEARCH CENTRE, MADRAS, BRITISH MEDICAL RESEARCH COUNCIL : A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Resp Dis 1992;145:36-41.
15. PAPE JW, JEAN SS, HO JL, HAFNER A, JONHSON WD : Effects of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72.